Timepoints (TP) for analyses | TP1 | TP2 | TP3 | TP4 | TP5 | ||
---|---|---|---|---|---|---|---|
Timepoints relative to treatment | Baseline, before treatment | During treatment | After treatment | ||||
Timeframe for each test | < 7 d of first ECT/TMS | 1–2 h before first ECT/TMS | 1–2 h after first ECT/TMS | before 7th ECT/11th TMS | 7–14 d after last ECT/TMS | 6 mo after ECT/TMS series | |
Clinical assessments c | Clinical examination | x | |||||
ECT- stimulus specific measures b | EEG, pulse width, charge, amplitude, frequency, pulse train duration, seizure duration, electrode placement and reorientation time | x | x | ||||
Current and concomitant medication | x | x | x | x | |||
Symptom severity c | MADRS [47] | x | x | x | x | ||
BDI [48] | x | x | x | x | |||
CGI [49] | x | x | x | x | |||
EMQ [50] | x | x | x | x | |||
MMSE [51] | |||||||
Radiology | MRI: T1, T2, MRS, ASL, DWI, rsfMRI | x | x | x | x | x | |
Neurocognitive assessments aligned with GEMRIC recommendation | x | x | x | ||||
2. Phonemic Fluency [54] | x | x | x | ||||
3. Semantic Fluency [54] | x | x | x | ||||
4. SDMT [55] | x | x | x | ||||
5. TMT A + B [54] | x | x | x | ||||
7. DSB [55] | x | x | x | ||||
8. AMT [56] | x | x | x | ||||
9. MoCa version 7.1 [57] | x | x | x | ||||
10. NART [58] | x | x | x | ||||
11. QIDS-SR 16 [59] | x | x | x | ||||
Study specific neurocognitive assessments | 1.VAMSa,c [60] | x | x | x | |||
3. Spatial navigation: Memory retrieval task [61, 62], Four Mountain [63], Sea Hero [64] | x | x | x | ||||
4. RCFT [65] | x | x | x | ||||
5. CWIT [54] | x | x | x | ||||
x | x | x | |||||
7. ECCA [68] c | x | x | x | ||||
Brain laterality, cognitive control | x | x | x | ||||
Blood samples | Serum, EDTA, PAX-gen | x | x | x | x | ||
Actigraphy | Empatica 4 [71] b | x | x | x | x | x |